Hormone replacement therapy in postmenopausal women protects against smoking-induced changes in vascular structure and function

Journal of the American College of Cardiology

Volumn 34, Issue 1, 1999, Pages 131-137

  Teede, Helena J ^a   Liang, Yu Lu ^a   Shiel, Louise M ^a   McNeil, John J ^a   McGrath, Barry P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; TRIACYLGLYCEROL;

ADULT; ARTERY COMPLIANCE; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD VESSEL; COMMON CAROTID ARTERY; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; INTRAVASCULAR ULTRASOUND; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; PROTECTION; SMOKING;

ARTERIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SMOKING; TRIGLYCERIDES; TUNICA INTIMA; VASCULAR DISEASES;

EID: 0033165754     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00155-2     Document Type: Article

References (42)

1. Bush T.L., Barrett-Connor E., Cowan L.D., et al. Cardiovascular mortality and noncontraceptive use of estrogen in women results from the lipid research clinics program follow-up study . Circulation. 75:1987;1102-1109.
2. Wolf P.H., Madans J.H., Finucane F.F., et al. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones evidence from a national cohort . Am J Obstet Gynecol. 164:1991;489-494.
3. Sullivan J.M., Vander Zwagg R., Lemp G.F., et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med. 108:1988;358-363.
4. Rajkumar C., Kingwell B., Cameron J., et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol. 30:1997;1-6.
5. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow mediated vasodilation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
6. Gordonski G.I. Mechanisms of action for estrogen in cardioprotection. Wren B., Progress in the Management of the Menopause. 1997;402-418 Parthenon, New York.
7. Barrett-Connor E., Wingard D., Criqui M.H. Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA. 261:1989;2095-2100.
8. Sack M.N., Rader D.J., Cannon R.O. Estrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:1994;267-270.
9. Williams J.K., Anthony M.S., Honore E.K., et al. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 15:1995;827-836.
10. Vargas R., Wroblewska B., Rego A., et al. Oestrodiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 109:1993;612-617.
11. Kon Koh K., Mincemoyer R., Minh N.B., et al. Effects of hormone replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med. 336:1997;683-690.
12. Kroon U.B., Silfverstolpe G., Tengborn L. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables. Thromb Haemost. 71:1994;420-423.
13. Celemajer D.S., Sorensen K., Georgakopoulos D., et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155.
14. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
15. Howard G., Sharrett A.G., Heiss G., et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC investigators. Stroke. 24:1993;1297-1304.
16. Bonithon-Kopp C. Prevalence of and risk factors for intima-media thickening a literature review . Touboul P.-J., Crouse J.R., Intima-Media Thickness and Atherosclerosis. Predicting the Risk? 1997;27-44 Parthenon, New York.
17. Crouse J.R. Association of arterial wall thickening and coronary disease. Touboul P.-J., Crouse J.R., Intima-Media Thickness and Atherosclerosis. Predicting the Risk? 1997;105-115 Parthenon, New York.
18. McGrath B.P., Liang Y.-L., Teede H.J., et al. Age-related deterioration in arterial structure and function in postmenopausal women the impact of hormone replacement therapy . Atheroscler Thromb Vasc Biol. 18:1998;1149-1156.
19. O'Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 15:1990;339-347.
20. Dart A.M., Lacombe A., Yeoh J.K., et al. Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet. 338:1991;270-273.
21. Kupari M., Hekali P., Keto P., et al. Relation of aortic stiffness to factors modifying the risk of atherosclerosis in healthy people. Atheroscler Thromb Vasc Biol. 14:1994;386-394.
22. Cameron J.D., Dart A.M. Exercise training increases total systemic arterial compliance in humans. Am J Physiol. 266:1994;H693-H701.
23. Bennett S.A., Mangus P. Trends in cardiovascular risk factors in Australia. Results from the National Heart Foundation's Risk Factor Prevalence Study, 1980-1989. Med J Aust. 161:1994;519-527.
24. Pignoli P., Tremoli E., Poli A., et al. Intimal plus medial thickness of the arterial wall a direct measurement with ultrasound imaging . Circulation. 74:1986;1399-1406.
25. Kanters S.D.J.M., Algra A., Van Leewen M.S., et al. Reproducibility of in vivo carotid intima-media thickness measurements. A review. Stroke. 28:1997;665-671.
26. Gamble G., Zorn J., Sanders G., et al. Estimation of arterial stiffness, compliance, and distensibility from M-mode ultrasound measurements of the common carotid artery. Stroke. 25:1994;11-16.
27. Liu Z., Brian K.P., Yin F.C.P. Estimation of total arterial compliance an improved method and evaluation of current methods . Am J Physiol. 251:1986;H588-H600.
28. Liang Y-L, Teede HJ, Kotsopoulos D, et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci 1998;95:669-79.
29. Wilson P.W.F., Garrison R.J., Castelli W.P. Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50. The Framingham study. N Engl J Med. 313:1985;1038-1043.
30. Manolio T.A., Furberg C.D., Shemanski L., et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88:(Part 1):1993;2163-2171.
31. Stampfer M.J., Willett W.C., Colditz G.A., et al. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med. 313:1985;1044-1049.
32. Lindenstrom E., Boysen G., Nyboc J. Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart study. Stroke. 24:1993;1468-1472.
33. Howard G., Burke G.L., Szklo M., et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities study. Arch Intern Med. 154:1994;1277-1282.
34. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med. 115:1991;455-456.
35. Adams M., Register T., Golden D., Wagner J., Williams K. Medroxyprogesterone acetate antagonises inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;217-221.
36. Espeland M.A., Applegate W., Furberg C.D., et al. Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study. Am J Epidemiol. 142:1995;1011-1019.
37. Williams J.K., Adams M.R., Clarkson T.B. Effects of estrogens on vascular tone. J Cardiovasc Pharmacol. 28:(Suppl 5):1996;s29-s33.
38. Jick H., Derby L.E., Myers M.W., Vasilakis C., Newton K.M. Risk of hospital admission for ideopathic venous thromboembolism among users of postmenopausal estrogens. Lancet. 348:1996;981-983.
39. Jensen J., Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol. 159:1988;820-825.
40. Cassidenti D.L., Vijod A.G., Vijod M.A., Stanczyk F.Z., Lobo R.A. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women. Am J Obstet Gynecol. 163:1990;1953-1960.
41. Baron J.A. Smoking and estrogen-related disease. Am J Epidemiol. 119:1984;9-22.
42. Jensen J. Smoking and postmenopausal hormone replacement therapy. Br J Clin Pract. 86:1996;6-9.